🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

3B Blackbio Dx Limited 3BBLACKBIO NSE

· India
https://3bblackbio.com
Company Profile ↓
₹1,202.10
-7.67% 1Y
P/E17.61
P/B3.13
52W High₹1,388.05
52W Low₹1,102.80
Book Value₹388.37
EPS (TTM)₹68.27

Company Overview

3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 18.5%, reflecting efficient use of shareholder capital.

Steady Revenue Expansion

Revenue has grown at a 20.1% CAGR over the past five years.

Reasonable Valuation

Trades at an undemanding P/E of 17.6.

Healthy Margins

Maintains a net profit margin of 42.2%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹142.00 Cr (+47.9% YoY); net profit ₹60.00 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +47.9%, earnings +25.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 20.1%, profit CAGR -12.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:20.06%
1 Year:47.92%

Compounded Profit Growth

5 Years:-12.05%
1 Year:25.00%

Stock Price Performance

1 Year:-7.67%
6 Months:-
3 Months:-
1 Month:-6.63%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 35% of range
₹1,102.80 ₹1,388.05
Trend Signals
  • Price vs 50-DMABelow
  • RSI (14)53.27 · Neutral
Price Performance
1M-6.63%
1Y-7.67%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Excellent profit margin of 42.2%.
  • Compounding revenue at 20.1% over 5 years.
  • Generates positive free cash flow.

CONS

  • Earnings shrank at -12.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
17.61
Industry PE
-
Forward P/E est.
14.09
PEG Ratio
-
Book Value
₹388.37
Price to Book
3.13
P/S
-
EV/EBITDA
15.92
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
20.06%
Profit 5Y
-12.05%
Revenue (YoY)
47.92%
Earnings (YoY)
25.00%

Profitability & Returns

ROCE
-
ROE
18.46%
ROA
15.87%
Profit Margin
42.25%
Op Margin
36.62%
Gross Margin
74.73%
EPS (Latest Qtr)
₹11.14
EPS (TTM)
₹68.27

Balance Sheet & Liquidity

Debt/Equity
0.92
Quick Ratio
4.12
Current Ratio
5.27
Debt
₹3.00 Cr
Total Assets
₹378.00 Cr
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
66.02%
Chg in Prom Hold
0.01%
FII / Inst Holding
1.95%
Chg in FII Hold
-2.60%

Financial Snapshot

Enterprise Value
₹931.40 Cr
Total Revenue (TTM)
₹142.00 Cr
EBITDA
₹57.00 Cr
Free Cash Flow
₹27.00 Cr
Operating Cash Flow
₹52.00 Cr
Shares Outstanding
-
Gross Margin
74.73%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 18.11 Cr14.28 Cr19.18 Cr17.67 Cr23.00 Cr19.43 Cr29.15 Cr25.39 Cr22.50 Cr22.23 Cr33.90 Cr50.35 Cr35.43 Cr
Operating Expenses 10.65 Cr7.84 Cr11.39 Cr8.80 Cr13.12 Cr8.48 Cr12.98 Cr10.32 Cr14.58 Cr10.40 Cr19.17 Cr28.63 Cr26.94 Cr
Operating Income 7.25 Cr6.25 Cr7.55 Cr8.55 Cr9.58 Cr10.68 Cr15.90 Cr14.80 Cr7.64 Cr11.55 Cr14.15 Cr21.34 Cr4.60 Cr
EBITDA 7.46 Cr6.44 Cr7.79 Cr8.87 Cr9.88 Cr10.95 Cr16.17 Cr15.07 Cr7.92 Cr11.83 Cr14.73 Cr21.72 Cr8.49 Cr
Interest Expense 4.00 L2.00 L4.00 L3.00 L4.00 L1.00 L3.00 L2.00 L4.00 L1.00 L4.00 L9.00 L10.00 L
Pretax Income 8.36 Cr9.19 Cr10.26 Cr11.15 Cr13.73 Cr14.36 Cr19.31 Cr17.79 Cr12.54 Cr15.86 Cr19.62 Cr26.84 Cr14.65 Cr
Tax Provision 3.16 Cr1.98 Cr2.67 Cr2.64 Cr4.94 Cr3.06 Cr4.44 Cr4.30 Cr4.50 Cr3.22 Cr4.58 Cr4.40 Cr4.85 Cr
Net Income 5.19 Cr7.21 Cr7.58 Cr8.51 Cr8.79 Cr11.30 Cr14.87 Cr13.49 Cr8.04 Cr12.65 Cr15.04 Cr22.44 Cr9.81 Cr
Diluted EPS 7.729.7110.4610.1610.3312.9717.0715.619.7914.6717.1425.3211.14

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 19.00 Cr17.00 Cr16.00 Cr23.00 Cr23.00 Cr29.00 Cr227.00 Cr81.00 Cr62.00 Cr74.00 Cr96.00 Cr142.00 Cr
Operating Expenses 18.00 Cr16.00 Cr14.00 Cr18.00 Cr16.00 Cr20.00 Cr77.00 Cr44.00 Cr33.00 Cr41.00 Cr46.00 Cr85.00 Cr
Operating Income 1.00 Cr2.00 Cr3.00 Cr5.00 Cr6.00 Cr8.00 Cr149.00 Cr36.00 Cr28.00 Cr32.00 Cr49.00 Cr52.00 Cr
EBITDA 1.00 Cr2.00 Cr3.00 Cr5.00 Cr7.00 Cr9.00 Cr150.00 Cr37.00 Cr29.00 Cr33.00 Cr50.00 Cr57.00 Cr
Interest Expense 1.00 Cr1.00 Cr1.00 Cr1.00 Cr00000000
Pretax Income 001.00 Cr5.00 Cr7.00 Cr10.00 Cr152.00 Cr43.00 Cr35.00 Cr44.00 Cr64.00 Cr77.00 Cr
Tax Provision 0019.00 L1.20 Cr1.75 Cr2.30 Cr38.00 Cr11.18 Cr9.45 Cr12.32 Cr16.00 Cr16.94 Cr
Net Income 001.00 Cr3.00 Cr5.00 Cr8.00 Cr114.00 Cr32.00 Cr26.00 Cr32.00 Cr48.00 Cr60.00 Cr
Diluted EPS 0.360.511.765.358.1810.24151.6642.8934.5537.4055.5768.27

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 25.00 Cr24.00 Cr26.00 Cr30.00 Cr36.00 Cr45.00 Cr194.00 Cr192.00 Cr214.00 Cr248.00 Cr296.00 Cr378.00 Cr
Total Equity 10.00 Cr10.00 Cr11.00 Cr18.00 Cr22.00 Cr32.00 Cr132.00 Cr153.00 Cr194.00 Cr223.00 Cr269.00 Cr325.00 Cr
Total Debt 8.00 Cr8.00 Cr9.00 Cr6.00 Cr6.00 Cr4.00 Cr2.00 Cr3.00 Cr2.00 Cr1.00 Cr03.00 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 01.00 Cr1.00 Cr2.00 Cr4.00 Cr7.00 Cr98.00 Cr37.00 Cr20.00 Cr27.00 Cr43.00 Cr52.00 Cr
Investing Cash Flow -0-0-0-1.00 Cr-1.00 Cr-1.00 Cr-70.00 Cr-28.00 Cr15.00 Cr-20.00 Cr-33.00 Cr-24.00 Cr
Financing Cash Flow -0-1.00 Cr-00-1.00 Cr1.00 Cr-2.00 Cr-15.00 Cr-5.00 Cr-4.00 Cr-3.00 Cr-1.00 Cr
Capital Expenditure 00-1.00 Cr-1.00 Cr-1.00 Cr-1.00 Cr-2.00 Cr-2.00 Cr-2.00 Cr-1.00 Cr-1.00 Cr-25.00 Cr
Free Cash Flow 01.00 Cr01.00 Cr3.00 Cr6.00 Cr96.00 Cr35.00 Cr18.00 Cr26.00 Cr42.00 Cr27.00 Cr
Net Change in Cash -0001.00 Cr2.00 Cr7.00 Cr26.00 Cr-6.00 Cr30.00 Cr3.00 Cr7.00 Cr28.00 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ------------
Operating Margin % 5.3%11.8%18.8%21.7%26.1%27.6%65.6%44.4%45.2%43.2%51.0%36.6%
Net Margin % 0.0%0.0%6.2%13.0%21.7%27.6%50.2%39.5%41.9%43.2%50.0%42.3%
ROE % 0.0%0.0%9.1%16.7%22.7%25.0%86.4%20.9%13.4%14.3%17.8%18.5%
ROCE % ------------

Shareholding Pattern

Insiders
66.02%
Institutions
1.95%
Public Float
5.73%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for 3BBLACKBIO

Google News ue, 07 Jul 2026

Price to book forward of 3B BlackBio Dx Ltd – NSE:3BBLACKBIO - TradingView

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNOERXelRreGJaX1p6SWcwNnhNcW9XSWgtbHhrbi0yektBeUhBeEd1ZExOeVVOdW5wUVBWY2tqMVpXb3kzU0gwdEZUWXcxN1Ezc3hSXzdMZ2xlV3Z3N1ZoYnVaamh2TUhhckZqQnA1czU1OUVJelZYSDhfamN1TC1UZ2lzVlVja1RjSmJuM0…

Google News Fri, 29 May 2026

3B BlackBio Dx FY26 profit rises 25.7% on strong revenue growth - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPSDFqekl3Rlh4cWc3SEVwTm4xUUhBSkdwWFdDcndld3BZb01SNzJKLVdQbVdQVFVzU1lHX1VrNzM2SmdjLU10dWpjdlcwRGlrb1A5VXNCUnAxUGU3R2dvM2dKRDVOWGJaczQ3RU1mbWVHRG9hTU8tSkw0RHVrUU9YZ0wwV2drbkhBeFR1YU…

Google News Sat, 03 Jan 2026

3B BlackBio Dx Ltd. Share Price Live Today - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPSTF5ZHpTVnBmdTBCazBzaXJoN21WRmhkTEViMDJNSHRYdnBaenJvZ1I0dUZNQS1lLVAwWUpBOTMxUVhkbXJMRHRYMkpVSThBVVBXZGFUQjdrU2wwMTZBYWJmX2ZfRXJUS2cxVHU1S3d0aFBWY0RWaVhaUkNSUlcwbVdrOA?oc=5" targe…

Google News ue, 17 Mar 2026

3B BlackBio Dx Limited Completes Analyst Meeting with Fair Value Capital - scanx.trade

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPdHNiZnhiczhkb3dpM0RrbW5aNXlJcGc5dnUwUWd5c1lSMzFyWHpXNDN2ZDNaS2NvelU1SmdveWJ5VndhQ3E2VnN0SGdNdWEyWjFqZXNzclB1Nk91VTlfQVNrYXpicGZwVDlLWnQzSUlLN2cwcVJjZmdEWTNocVc3TFpPNW9ZTFdvSXJhT2…

Google News Fri, 29 May 2026

3B BlackBio Q4 EBITDA Jumps 18.9% to ₹11.3 Cr with 45.8% Margin - Sahi

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQN3M5ekdvVVdfNEI1R1RPd2tUandhSnpkQnpLcGF1YVBwUXRGT01iMXp5a2FGb0lLRFpwOVYxU21ackFPckpDOXhic1JqdFZyYWZONlpxSXdRZFNLcWxjYm1XaVBFN200WWlsT0xhMHJDU3ByTnlZSWtWeEdBcmx1b1YzLU45bWxVWEZwbV…

Google News ue, 27 Feb 2024

3B BlackBio Dx Ltd Share Price Today | 3B Blackbio Dx Live NSE/BSE - Value Research

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE5oekpXVEJrM2tUSFk1cGlXYVBxc1RHYjV2OHFSMHI0emJ4M1J2a1VhYUFTWDhzWEFkUVFPbmdrQnNWUkV2Nl9DSjhNQ0JONnhaR1RzUzE3elZmMlNUZ0FMeE1TQXBjNHpxNmZUOFdhdThOcEd5a1Y0?oc=5" target="_blank">3B Blac…

3BBLACKBIO — Frequently Asked Questions

What is the current share price of 3B Blackbio Dx Limited (3BBLACKBIO)?

As of 2026-07-15 09:52 IST, 3B Blackbio Dx Limited (3BBLACKBIO) trades at ₹1,202.10 on NSE. Its 52-week range is ₹1,102.80 to ₹1,388.05.

What is the P/E ratio of 3BBLACKBIO?

3BBLACKBIO trades at a trailing price-to-earnings (P/E) ratio of 17.61. Its price-to-book (P/B) ratio is 3.13.

What is the return on equity (ROE) of 3BBLACKBIO?

3BBLACKBIO has a return on equity (ROE) of 18.46%.

Is 3BBLACKBIO a good stock to buy?

This page provides a data-driven analysis of 3B Blackbio Dx Limited (3BBLACKBIO), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space